Literature DB >> 10027864

Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators.

N A Callejas1, A Castrillo, L Boscá, P Martín-Sanz.   

Abstract

Primary cultures of fetal hepatocytes expressed cyclooxygenase-2 (COX-2) upon stimulation with bacterial lipopolysaccharide (LPS) or peroxisomal proliferators. This enzyme was active and a good correlation between the mRNA levels, the amount of protein, and the synthesis of prostaglandin E2 was observed. However, when cells were incubated in the presence of indomethacin or the COX-2-specific inhibitor NS398, the amount of COX-2 protein increased 5-fold after activation with LPS and 2-fold after treatment with clofibrate. This up-regulation of COX-2 was not observed at the mRNA level. The mechanism of protein accumulation might involve either a direct stabilization of the enzyme by the inhibitors or the absence of prostaglandins involved in the regulation of its turnover. Among the prostaglandins assayed, only 15-deoxy-Prostaglandin J2 exerted a statistically significant decrease in the COX-2 levels in cells stimulated with LPS or LPS plus NS398. The accumulation of COX-2 in the presence of inhibitors was also observed in peritoneal macrophages treated under identical conditions. These results indicate that COX-2 protein accumulates after enzyme inhibition, and because removal of the inhibitors restored the enzyme activity, suppression of treatment with reversible COX-2 inhibitors may cause a transient overproduction of prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027864

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.

Authors:  Joong-Won Park; Jung Eun Park; Jung Ahn Lee; Chang-Woo Lee; Chang-Min Kim
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-06       Impact factor: 4.553

2.  Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Epilepsia       Date:  2011-01-10       Impact factor: 5.864

3.  Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines.

Authors:  Samir S Ayoub; Regina M Botting; Amrish N Joshi; Michael P Seed; Paul R Colville-Nash
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

4.  PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

5.  The Effect of Cadmium on COX-1 and COX-2 Gene, Protein Expression, and Enzymatic Activity in THP-1 Macrophages.

Authors:  Tomasz Olszowski; Izabela Gutowska; Irena Baranowska-Bosiacka; Katarzyna Piotrowska; Jan Korbecki; Mateusz Kurzawski; Dariusz Chlubek
Journal:  Biol Trace Elem Res       Date:  2015-02-03       Impact factor: 3.738

6.  Phlorotannins from Fucus vesiculosus: Modulation of Inflammatory Response by Blocking NF-κB Signaling Pathway.

Authors:  Marcelo D Catarino; Ana Silva; Maria T Cruz; Nuno Mateus; Artur M S Silva; Susana M Cardoso
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

7.  Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.

Authors:  O Núñez; A Fernández-Martínez; P L Majano; A Apolinario; M Gómez-Gonzalo; I Benedicto; M López-Cabrera; L Boscá; G Clemente; C García-Monzón; P Martín-Sanz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.